← Back to context

Comment by engelo_b

17 days ago

[dead]

The compound pharmacies are the leeches I have the least amount of sympathy for. While Lilly may gouge on the price, at least they can claim to have invented the drug. Some compound pharmacy buying $20 worth of API from China and selling it reconstituted for at least 10x that is just raking in huge profit, and they did none of the R&D.

What the FDA will probably have trouble cracking down on are the vendors selling lyophilized peptides direct to the public. And the number of people going that route goes up dramatically over time.

  • Who are these unscrupulous vendors selling direct to the public? Please name them so I can avoid them for my own personal safety.

    • The Atlantic did a write-up in December [0] about retatrutide availability and they named at least one well known vendor (who also sells tirzepatide, semaglutide, and all the other usual peptides). Not the cheapest vendor, but well known, does the batch lyophilization in the US, still takes credit cards, and gets pretty solid group test participation due to their popularity. And if you know how their pre-sales work, the price premium isn't too terrible, worth it for the test participation IMO.

      If you want to know who else to avoid, join the Discord the vendor links to from their web page and ask around in the general discussion topics, people will share.

      [0] https://archive.ph/n0daP

      2 replies →

We've been hearing these claims for a long time that they're going to crack down soon.